Evidence map›Paper›PMID 37508184›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Impact of SARS-CoV-2 Preventive Measures against Healthcare-Associated Infections from Antibiotic-Resistant ESKAPEE Pathogens: A Two-Center, Natural Quasi-Experimental Study in Greece.

Emmanouil Bolikas, Eirini Astrinaki, Evangelia Panagiotaki, Efsevia Vitsaxaki, Stamatina Saplamidou, Ioannis Drositis, Dimitra Stafylaki, Georgios Chamilos, Achilleas Gikas, Diamantis P Kofteridis and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Emmanouil BolikasLaboratory of Biostatistics, School of Medicine, University of Crete, 71003 Heraklion, Greece.ORCID 0000-0001-7135-3258
Eirini AstrinakiInfection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.
Evangelia PanagiotakiInfection Control Committee, Venizeleio-Pananeio General Hospital, 71409 Heraklion, Greece.
Efsevia VitsaxakiInfection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.
Stamatina SaplamidouInfection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.
Ioannis DrositisInfection Control Committee, Venizeleio-Pananeio General Hospital, 71409 Heraklion, Greece.
Dimitra StafylakiDepartment of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, 71110 Heraklion, Greece.
Georgios ChamilosInfection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.
Achilleas GikasInfection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.
Diamantis P KofteridisInfection Control Committee, University Hospital of Heraklion, 71110 Heraklion, Greece.ORCID 0000-0003-0255-5926
Evangelos I KritsotakisLaboratory of Biostatistics, School of Medicine, University of Crete, 71003 Heraklion, Greece.ORCID 0000-0002-9526-3852
University Hospital of Heraklion · GRUniversity of Crete · GRThe General Hospital of Heraklion "Venizeleio-Pananio" · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic led to unprecedented stress on healthcare systems worldwide, forming settings of concern for increasing antimicrobial resistance. We investigated the impact of SARS-CoV-2 preventive measures against healthcare-associated infections (HAIs) from antibiotic-resistant bacteria in two tertiary-care hospitals. We compared infection rates between March 2019 and February 2020 (pre-intervention period) and March 2020 and February 2021 (COVID-19 intervention period) from drug-resistant ESKAPEE bacteria (methicillin-resistant

Indexed as

antibiotic resistanceepidemiologyhealthcare-associated infectioninfection controlmultidrug resistanceSARS-CoV-2

Identifiers

PMID37508184
PMCPMC10376605
OpenAlexW4381741962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.